:MSRB1

Jingsong Cheng1, Diyuan Zhang2, Ningxi Wang3

  • 1Department of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing 400038, China; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou 510275, China; The Second Clinical College, Chongqing Medical University, Chongqing 400016, China.

概括

这项研究揭示了与乳腺癌 (BRCA) 风险之间的保护性联系. 一个新的相关风险评分预测患者的结果和治疗反应,确定MSRB1作为关键的治疗标.